Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05673759 · ClinicalTrials.gov registry record
Event-Related Potential (ERP) Components in Clinical Diagnosis
A clinical trial, sponsored by Boston University.
- Terminated
- Registry status
- 148
- Enrollment target
NCT05673759: Clinical Trial study, sponsored by Boston University.
NCT05673759 is a clinical trial that was terminated before completion, run by Boston University. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05673759 was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- 148 participants
- Enrollment target
Study Summary
In this study, the investigators will use a novel electroencephalogram (EEG) system that participants will wear during a single in-person research session to investigate whether ERPs are now ready for validation as a tool clinicians can easily implement to increase diagnostic accuracy and confidence. This EEG will not be used to treat, cure, mitigate or diagnosis any disease and there will be no safety or efficacy data collected about the machine for any purpose including support of FDA submission. The investigators will compare the ERP data to that of neuropsychological testing in order to determine the degree of correlation between these two measures. Questionnaires on cognition, mood, and fluency will be administered prior to the EEG to establish a baseline. ERP data from the EEG session will be compared with the results of the neuropsychological battery in order to determine whether the implementation of ERPs in the existing workflow of clinicians can aid in diagnostic accuracy, thus altering clinical management.
Primary Outcome
The EEG memory diagnosis will be arrived through the blinded review of the EEG data
Interventions
- DEVICE Electroencephalogram (EEG) system
- BEHAVIORAL Standard Neuropsychological Testing
- BEHAVIORAL Additional neuropsychological tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2023-03-06 |
| Est. Completion | 2025-05-01 |
Why NCT05673759 stopped before completion
NCT05673759 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Electroencephalogram (EEG) system is the first listed.
NCT05673759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05673759 about?
NCT05673759 is a clinical study titled "Event-Related Potential (ERP) Components in Clinical Diagnosis". In this study, the investigators will use a novel electroencephalogram (EEG) system that participants will wear during a single in-person research session to investigate whether ERPs are now ready for validation as a tool clinicians can easily implement to increase diagnostic accuracy and confidence...
What is the current status of trial NCT05673759?
This trial is currently terminated. The enrollment target is 148 participants. The study started on 2023-03-06. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT05673759?
The interventions under investigation include: Electroencephalogram (EEG) system (DEVICE), Standard Neuropsychological Testing (BEHAVIORAL), Additional neuropsychological tests (BEHAVIORAL).
Who is sponsoring clinical trial NCT05673759?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI